Loading data
HELENasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.79 bn USD | 1.91 bn USD | 2.01 bn USD | 2.07 bn USD | 2.22 bn USD |
| Cost of revenue | 970.6 m USD | 993.26 m USD | 1.06 bn USD | 1.17 bn USD | 1.27 bn USD |
| Gross profit | 815.69 m USD | 914.41 m USD | 948.66 m USD | 899.35 m USD | 953.19 m USD |
| Research and development expense | 54 m USD | 53.9 m USD | 56.5 m USD | 47.8 m USD | 54 m USD |
| Selling, general and administrative expense | 708.91 m USD | 705.38 m USD | 669.36 m USD | 660.2 m USD | 680.26 m USD |
| Operating profit | -782.08 m USD | 142.75 m USD | 260.59 m USD | 211.79 m USD | 272.55 m USD |
| Interest expense | — | — | 53.07 m USD | 40.75 m USD | 12.84 m USD |
| Profit before tax | -838.84 m USD | 91.66 m USD | 209.04 m USD | 171.29 m USD | 259.97 m USD |
| Income tax expense | 60.14 m USD | -32.09 m USD | 40.45 m USD | 28.02 m USD | 36.2 m USD |
| Net income (reported basis) | -899 m USD | 124 m USD | 169 m USD | 143 m USD | 224 m USD |
| Basic earnings per share | -39.08 USD/share | 5.38 USD/share | 7.06 USD/share | 5.98 USD/share | 9.27 USD/share |
| Diluted earnings per share | -39.08 USD/share | 5.37 USD/share | 7.03 USD/share | 5.95 USD/share | 9.17 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.